Your browser doesn't support javascript.
loading
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
Lowe, David M; Brown, Li-An K; Chowdhury, Kashfia; Davey, Stephanie; Yee, Philip; Ikeji, Felicia; Ndoutoumou, Amalia; Shah, Divya; Lennon, Alexander; Rai, Abhulya; Agyeman, Akosua A; Checkley, Anna; Longley, Nicola; Dehbi, Hakim-Moulay; Freemantle, Nick; Breuer, Judith; Standing, Joseph F.
Afiliação
  • Lowe DM; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
  • Brown LK; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Chowdhury K; Institute of Immunity and Transplantation, University College London, London, United Kingdom.
  • Davey S; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom.
  • Yee P; Department of Rheumatology, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Ikeji F; Department of Rheumatology, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Ndoutoumou A; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom.
  • Shah D; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom.
  • Lennon A; Department of Virology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.
  • Rai A; Department of Virology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.
  • Agyeman AA; Department of Virology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.
  • Checkley A; Infection, Immunity and Inflammation Research and Teaching Department, Institute of Child Health, University College London, London, United Kingdom.
  • Longley N; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Dehbi HM; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Freemantle N; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom.
  • Breuer J; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom.
  • Standing JF; Department of Virology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.
PLoS Med ; 19(10): e1004120, 2022 10.
Article em En | MEDLINE | ID: mdl-36260627
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: PLoS Med Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: PLoS Med Ano de publicação: 2022 Tipo de documento: Article